Dosing regimen patents scrutinized by the Federal Circuit
In this article for Reuters Legal, partners Jeanna Wacker and Tasha Francis Gerasimow and law clerk Eliana Applebaum discuss two Federal Circuit cases relating to the validity of dosing regimen patents.
Related Professionals
This article was originally published on March 23, 2022 by Reuters Legal News. Further reproduction without permission is prohibited.